Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Clinical characteristics and nosological considerations.
D000293:Adolescent; D000367:Age Factors; D001264:Athetosis / Q000473:pathology*; D001369:Axons; D001479:Basal Ganglia / Q000473:pathology; D001927:Brain Diseases / Q000235:genetics*; D003937:Diagnosis, Differential; D005260:Female; D005917:Globus Pallidus / Q000473:pathology; D006801:Humans; D009069:Movement Disorders; D009223:Myotonic Dystrophy / Q000473:pathology*; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000473:pathology; D010860:Pigments, Biological; D012640:Seizures / Q000209:etiology; D013064:Speech Disorders / Q000209:etiology; D013378:Substantia Nigra; D013577:Syndrome; D013788:Thalamus / Q000473:pathology; D014786:Vision Disorders / Q000209:etiology
D010860:Pigments, Biological